Since YouGov was in the middle of conducting its survey when the government announced its recommendation to pause the J&J vaccine, the pollster was able to analyse whether the news affected opinions about vaccinations. YouGov also found that 59% of respondents had been or were planning to get vaccinated, compared with 23% who said they would not get a jab. Overall, 48% of respondents said they thought the J&J vaccine was safe, compared with 30% who thought it was unsafe confidence in the Pfizer and Moderna shots were 58% and 59%, respectively.
Between April 10th and 13th YouGov, a pollster, asked 1,500 Americans whether they thought the J&J dose was safe and whether they have been vaccinated or plan to do so when it is their turn. New polling data confirm some fears, but dispel others. Critics worried the decision might appear to give sceptics justification for their reluctance. Proponents hoped that by seriously addressing potentially harmful side-effects, regulators would boost confidence in vaccines.
American regulators were spooked after some recipients of the jab developed rare but severe blood clots. The US Food and Drug Administration (FDA) will review the analysis, the agencies said in a joint statement.LAST WEEK America’s Centres for Disease Control and Prevention (CDC) and Federal Drug Administration (FDA) recommended that covid-19 vaccination sites temporarily stop administering the jab made by Johnson & Johnson (J&J), a one-dose alternative to the more popular two-shot variants from Pfizer and Moderna. The one shot vaccine will not be made available to Australians after the Morrison Government made a decision not to move forward with it earlier this week.Īn advisory committee to the US Centers for Disease Control and Prevention (CDC) will meet on Wednesday (local time) to review the clotting cases. Johnson & Johnson said it would delay the rollout of its COVID-19 vaccine in Europe and was reviewing cases of extremely rare blood clots in people after they received the shot with European health authorities. LIVE UPDATES: Read our blog for the latest news on the COVID-19 pandemic The move comes a week after European regulators said they had found a possible link between AstraZeneca's COVID-19 vaccine and a similar rare blood clotting problem that led to a small number of deaths. In the cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia).Īs of April 12, more than 6.8 million doses of the Johnson & Johnson vaccine had been administered in the US, compared with more than 180 million doses of both the Moderna and Pfizer/BioNTech shots. Dr Anthony Fauci wanted to assure Americans who have had the Johnson & Johnson vaccine there is no need to panic.Įarlier on Tuesday (local time), US federal health agencies recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six women under 50 developed rare blood clots since receiving the shot.Īll six cases involved women between the ages of 18 and 48, and the symptoms occurred six to 13 days after vaccination.
0 kommentar(er)
